Evidence map›Paper›PMID 31077191›Full record

ArticleBMC ophthalmology2019

Clinical study on combining femtosecond thin- flap and LASIK with the Triple-A profile for high myopia correction.

Kai Li, Chuan-Wei Zhang, De-Jian Hong, Jing Wu, Yi-Shuo Yao

Open access · goldAbstract read
In one paragraph

Article in BMC ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kai LiDepartment of Ophthalmology, Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing, 155 Hanzhong Road, Nanjing, 210029, Jiangsu, China. likai8922@163.com.ORCID http://orcid.org/0000-0002-3015-9923
Chuan-Wei ZhangDepartment of Ophthalmology, Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing, 155 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
De-Jian HongDepartment of Ophthalmology, Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing, 155 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
Jing WuDepartment of Ophthalmology, Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing, 155 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
Yi-Shuo YaoDepartment of Ophthalmology, Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing, 155 Hanzhong Road, Nanjing, 210029, Jiangsu, China.
Nanjing University of Chinese Medicine · CN

Funding

Six Talent Peaks Project in Jiangsu Province WSW 048
6 · The paper itself

Abstract

backgroundFemtosecond laser-assisted LASIK (FS-LASIK) can make ultra-thin corneal flap accurately. MEL 90 excimer laser provides Triple-A ablation mode, which significantly reduces the amount of corneal tissue cutting. This study aimed to investigate the visual and refractive outcomes in patients with high myopia after thin-flap FS-LASIK using the 500 Hz pulse rate of the Triple-A profile.

methodsThis prospective study included 90 eyes from 90 patients received thin-flap FS-LASIK using the 500 Hz pulse rate of the Triple-A profile. According to the pre-operative spherical equivalence (SE), the treated eyes were divided into two groups: the first group (ranged from - 9.0D to - 6.0D) and the second group (ranged from - 11.15D to - 9.0 D). The parameters evaluated pre-operatively and 6 month post-operatively included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), SE, efficacy and safety index, posterior central elevation, and corneal higher-order aberrations (HOAs).

resultsThe efficacy indexes were 1.149 ± 0.150 for the first group and 1.173 ± 0.136 for the second group (P > 0.05), whereas safety indexes were 1.135 ± 0.154 and 1.158 ± 0.137 (P > 0.05) respectively. Moreover, 93.8 and 90.6% of patients had an UDVA of 20/20, 51.2 and 49.8% had a UDVA of 20/16 for the first and second groups, respectively; yet, there were no significant differences between both groups at the 20/20 and the 20/16 levels (P > 0.05). 84 and 100% of the firse group patients had a SE within ±0.5 D and ± 1.0 D, and 82 and 100% of the second group patients. There was no significant myopia regression in both groups after 6 months follow-up. At 1, 3 and 6-month after surgery, there were no significant differences in the posterior central elevation between the two groups (P > 0.05). The induction of total HOAs, spherical aberration, and horizontal coma in the first group were significantly less than that in the second group at the 6- month follow-up (P < 0.05), while the differences of the RMS value of vertical coma between both groups were not significant (P > 0.05). The ablation was significantly associated with the post-operative increase in total HOAs, spherical aberration and horizontal coma (P < 0.05),but not with vertical coma (P > 0.05).

conclusionOur results indicate that using the Triple-A ablation profile of the MEL 90 excimer laser associated with thin-flap is a safe, efficient, and predictable method to correct SE up to - 11.15D. However, for patients with high myopia, under the premise of ensuring a certain optical zone diameter, the ablation depth should be minimized to reduce the increase of the post-operative HOAs so as to improve the visual quality.

Indexed as

Lasers, ExcimerSurgical FlapsAdolescentAdultCorneal Wavefront AberrationFemaleHumansKeratomileusis, Laser In SituMaleMyopia, DegenerativeProspective StudiesRefraction, OcularVisual AcuityYoung AdultFemtosecond LASIKHigh myopiaLaser refractive surgeryTriple-A procedureVisual acuity

Identifiers

PMID31077191
PMCPMC6509790
OpenAlexW2947518704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.